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We have previously studied the activities of lipoprotein lipase and hepatic lipase in postheparin plasma from patients with secondary hypertriglyceridemia as a result of uncontrolled glycogen storage disease (10, 11) . These patients had greatly reduced activities of both lipoprotein and hepatic lipase which resulted from the presence of a circulating inhibitor (11).
Reduced activities oflipoprotein lipase and hepatic lipase have been previously reported in patients with SRNS (12) and rats with experimental nephrosis (7) but the mechanism has not been established. Reduced enzymatic activities could result from a quantitative reduction in enzyme protein , an inhibition of enzymatic activity or an abnormal interaction between heparin and the lipase at the capillary endothelium. In this study we investigated the possibility that the reduced enzymatic activity may result from the presence of a circulating inhibitor.
Patients. Fourteen children (10 males and four females) aged 3-16 yr with SRNS were studied. Five had minimal change histology and in the remainder this was presumed on the basis of steroid response. They were in relapse (3 + proteinuria using Albustix) and were not receiving steroid therapy at the time of study. Five patients (four male and one female) aged 6-16 yr with familial hypercholesterolemia were studied while on a fat modified diet or receiving cholestyramine (Bristol Laboratories, Slough, England). The diagnosis was based on standard criteria (13) . A control group of 12 children (10 males and two females) aged 12-14 yr was studied. These children were part of the Chard study of normal growth and adolescence which was approved by the Ethical Committee of the Hospitals for Sick Children, London.
Methods. Postheparin Plasma. Postheparin plasma was obtained from a healthy adult by venepuncture exactly 10 min after an intravenous injection of heparin (IOU/kg body weight). Blood was collected into glass tube s containing dipotassium EDT A (1.5 mg/rnl) and the postheparin plasma was stored in aliquots at -20· C and used throughout as source of normal lipoprotein lipase activity.
Inhibitor Studies. Blood was collected from the children under investigation into 3.8% sodium citrate (I: 10 vIv). The plasma was separated and stored at -70· C prior to assay. The inhibition of normal lipoprotein lipase activity was estimated by mixing 50 III of the test plasma with 50 III of the normal post-heparin plasma and assaying the lipoprotein lipase activity essentially as described previously using tritiated (9,10-3H)g1ycerol trioleate as substrate (10) . A final concentration of sodium chloride of 0.075 mol/liter was used throughout and aliquots of the reaction mixture were removed at 40, 55, and 70 min. The radiolabeled 197 ABSTRACf. The study was designed to investigate the hyperlipidaemia associated with the steroid responsive nephrotic syndrome in children and in particular to examine the mechanism for the delayed clearance of the circulating triglyceride-rich lipoproteins. The possibility that plasma from patients with steroid responsive nephrotic syndrome may contain an inhibitor of lipoprotein lipase activity was studied by examining the effect of the addition of plasma from patients, on normal postheparin lipoprotein lipase activity. Plasma from children with steroid responsive nephrotic syndrome significantly inhibited lipoprotein lipase activity (p < 0.001), whereas that from patients with familial hypercholesterolaemia and normal children had no significant effect. The inhibition of lipoprotein lipase activity by plasma from patients with steroid responsive nephrotic syndrome correlated significantly with their increased plasma cholesterol and reduced plasma albumin concentrations (p < 0.001 and < 0.02, respectively), but there was no significant correlation with plasma triglyceride concentrations. Thus , the degree of inhibition probably reflected the severity of the condition at the time of study. Neither the cholesterol, albumin nor triglyceride concentrations appeared to directly influence the lipoprotein lipase activity of postheparin plasma. Hyperlipidaemia is a characteristic feature of SRNS, with untreated patients having increased plasma concentrations of cholesterol and triglyceride, and lipoprotein carriers, chylomicrons, very low density, intermediate density, and low density lipoproteins (1-3). Studies on the mechanism of the hyperlipidemia suggest that there is both an increased synthesis and secretion of the lipoproteins (4-7) as well as a reduced clearance of circulating triglyceride (4) (5) (6) (7) (8) .
Triglycerides are transported in the circulation by the triglyceride-rich lipoproteins (chylomicrons and very low density lipoproteins) which are cleared from the circulation by the action of lipoprotein lipase. This enzyme is located on the capillary endothelium of extrahepatic tissues but can be released into the circulation by low doses of intravenous heparin. Postheparin fatty acids released by lipolytic actrvity were extracted and counted on an LKB Wallac Ultrabeta liquid scintillation counter using external standardisation for quench correction . Addition of plasma from normal children gave the expected activity with no significant inhibition. A pool of plasma samples from normal children was therefore used as a quality control in each batch of assays and assigned an activity of 100%. The results of the test samples were expressed as a percentage of this quality control value.
Miscellaneous Methods. Plasma triglyceride and cholesterol concentrations were measured enzymatically using commerical kits supplied by Metachem Diagnostics and Abbott Laboratories Limited, respectively. Serum albumin concentrations were estimated by single radial gel diffusion (14) .
Statistics. Results are expressed throughout as mean ± I SO and the significance of differences between mean values was calculated by the Student's t test. Correlation coefficients were derived from linear regression analysis.
RESULTS
The fasting plasma triglyceride, cholesterol, and albumin concentrations in the children with SRNS and familial hypercholesterolemia and the control children are shown in Table 1 . The children with SRNS had significantly increased fasting triglyceride and cholesterol concentrations (p < 0.02 and < 0.001, respectively)and a significantly reduced plasma albumin concentration (p < 0.01) compared to the controls. The children with familial hypercholesterolemia had a significantly raised plasma cholesterol concentration (p < 0.00 I) which was not significantly different from that observed in SRNS.
The effect of adding plasma from patients in the various clinical groups to a normal postheparin plasma sample is shown in Figure I . Results are expressed as the percentage of the lipoprotein lipase activity obtained with the quality control specimen. The activities obtained with the plasmas from the 12 control children were distributed around the quality control value (104.6 ± 10.5%). Plasma from the children with SRNS showed a significant inhibition (p < 0.001) of the lipoprotein lipase activity (68.4 ± 22.0%) whereas that from the patients with familial hypercholesterolemia did not differ significantly from the control values (91.7 ± 14.0%).
The percentage ofthe quality control lipolytic activity obtained with the SRNS samples was correlated with the plasma lipid and albumin concentrations (Fig. 2) . A significant positive correlation (p < 0.02) was found with the albumin concentration and a significant negative correlation (p < 0.001) was observed with plasma cholesterol concentrations but there was no significant correlation with plasma triglyceride concentrations.
To investigate whether the inhibition of lipoprotein lipase activity resulted directly from either the reduced albumin or increased triglyceride concentrations, increasing amounts of albumin were added to a plasma sample from a patient with SRNS and increasing amounts of triglyceride in the form of Intralipid (Kabi Vitrum, UK) to three control plasma samples. The final concentrations of albumin and triglyceride ranged from 10 to 45 gfliter and 1 to IS mmol/liter, respectively. The highest triglyceride concentrations (15 mmol/liter) tended to give a slight reduction of lipoprotein lipase activity (80% of starting activity) (seeFig. 3) but otherwise there was no effect on lipolytic activity. DISCUSSION We have previously observed that patients with SRNS show a decreased sensitivity to the anticoagulant effect of heparin (15) . The release of lipoprotein and hepatic lipase from the capillary endothelium into the blood stream by heparin may therefore also be impaired in SRNS, resulting in reduced activities of these enzymes in postheparin plasma from patients with this condition. For this reason we decided not to estimate postheparin lipolytic activity directly but to investigate the possible inhibitory activity of plasma from children with SRNS by adding it to normal postheparin plasma and assaying the lipoprotein lipase activity. Using this approach we observed a highly significant inhibition of lipoprotein lipase activity with plasma samples from children with SRNS, whereas plasma from patients with familial hypercholesterolemia or normal controls showed no inhibition. The range of inhibition observed in SRNS was wide and probably reflected variation in the severity of the condition at the time of study. This was suggestedby the significant correlation ofincreasing inhibition of lipolytic activity with decreasing plasma albumin and increasing cholesterol concentrations.
The nature of the inhibito r is not known. It does not appear to be a consequence of increased substrate concentration as increasing the triglyceride concentration in vitro over the range found in the plasma specimens did not inhibit the enzyme activity. We have also previously shown that postheparin plasma 200 VERMYLEN ET AL.
from a patient with type I hyperlipoproteinemia and a triglyceride concentrations of 7 mmolfliter was not inhibitory (II).
Similarly the addition of albumin to nephrotic plasma did not significantly alter the lipoprotein lipase activity. This is in agreement with the observation of Marsh (6) that the intravenous injection of albumin into rats with experimental nephrosis did not correct the catabolic defect, although others have reported that albumin can reverse the hyperlipemia in patients with the nephrotic syndrome (I 6).
It has been reported that increased cholesterol concentrations can inhibit lipoprotein lipase activity (17) . In our study, however, plasma cholesterol concentrations were similar in the patients with SRNS and familial hypercholesterolemia, and plasma from the latter group of patients did not show significant inhibition . Lipoprotein lipase requires a cofactor, apoprotein Cll , for activity but this apoprotein is present in large amounts in patients with SRNS (6), and the absence of an activator is unlikely to account for the observed inhibition of norrnallipoprotein lipase activity.
There is evidence that proteinuria in SRNS is caused by a loss of negative charge on the glomerulus (18) . A loss of surface charge on red blood cells and platelets has also been reported (19) and this together with the reduced sensitivity to heparin in SRNS suggeststhe presence of a circulating cationic macromolecule. The site of action and the activity oflipoprotein lipase are effected by charged macromolecules. Thus lipoprotein lipase binds to negatively charged glycosaminoglycans (probably heparan sulphate) at the capillary endothelium via a specific binding site (20) . The enzyme is inhibited by protamine and there is evidence that it can be activated in vitro by heparan sulfate (21). It is therefore possible that the presence of a circulating cationic macromolecule may be responsible for the inhibition oflipoprotein lipase activity in SRNS.
We have previously documented the presence of a circulating inhibitor of lipoprotein lipase and hepatic lipase activity in patients with glycogen storage disease (II) and preliminary results suggestthat plasma from children with uncontrolled insulindependent diabetes mellitus is also inhibitory . It therefore appears that a number of secondary hyperlipidemic conditions may result at least in part from the presence of circulating inhibitor(s) of lipoprotein lipase activity with a consequent decrease in the rate of clearance of the triglyceride-rich lipoproteins.
